We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Optical Coherence Tomography Provides High-resolution, 3D Images of the Eye

By Biotechdaily staff writers
Posted on 15 May 2007
By conducting research that could improve diagnoses of many eye diseases, investigators have developed a new type of laser for taking high-resolution, three-dimensional (3D) images of the retina, the region of the eye that converts light to electrical signals that travel to the brain.

The study, performed by researchers from the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA), were presented at the Conference on Lasers and Electro-Optics and the Quantum Electronics and Laser Science Conference in Baltimore, MD, USA, on May 10, 2007.

The new imaging system is based on optical coherence tomography (OCT), which uses light to obtain high-resolution, cross-sectional images of the eye to visualize slight changes that occur in retinal disease. More...
OCT was developed in the early 1990s by MIT professor Dr. James Fujimoto, Dr. Eric Swanson at MIT Lincoln Laboratory and collaborators; Dr. Fujimoto is an author of the study.

Conventional OCT imaging characteristically yields a series of two-dimensional cross-sectional images of the retina, which can be combined to form a 3D image of its volume. The system functions by scanning light back and forth across the eye, measuring the echo time delay of reflected light along micrometer-scale lines that, row by row, build up high-resolution images.

Commercial OCT systems scan the eye at rates ranging from several hundred to several thousand lines per second. But a typical patient can only keep the eye still for about one second, limiting the amount of 3D data that can be acquired. Now, using the new laser, researchers in Dr. Fujimoto's group reported retinal scans at record speeds of up to 236,000 lines per second, a factor-of-10 improvement over current OCT technology.

Future clinical studies, as well as additional development, may someday enable ophthalmologists to routinely obtain three-dimensional "OCT snapshots” of the eye, containing comprehensive volumetric data about the microstructure of the retina. Such snapshots could potentially improve diagnoses of retinal diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration.


Related Links:
Massachusetts Institute of Technology

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.